BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32160823)

  • 21. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations.
    Pace LE; He Y; Keating NL
    Cancer; 2013 Jul; 119(14):2518-23. PubMed ID: 23605683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interval cancer rates in the Irish national breast screening programme.
    O'Brien KM; Dwane F; Kelleher T; Sharp L; Comber H
    J Med Screen; 2015 Sep; 22(3):136-43. PubMed ID: 25917389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difficult Access and Poor Productivity: Mammography Screening in Brazil.
    Rodrigues DCN; Freitas-Junior R; Rahal RMS; Correa RDS; Peixoto JE; Ribeiro NV; Ferreira NC; Soares LR
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1857-1864. PubMed ID: 31244310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
    Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
    Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
    Tabár L; Dean PB; Chen TH; Yen AM; Chen SL; Fann JC; Chiu SY; Ku MM; Wu WY; Hsu CY; Chen YC; Beckmann K; Smith RA; Duffy SW
    Cancer; 2019 Feb; 125(4):515-523. PubMed ID: 30411328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results.
    Narayan A; Fischer A; Zhang Z; Woods R; Morris E; Harvey S
    Breast Cancer Res Treat; 2017 Aug; 164(3):719-725. PubMed ID: 28508184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast Cancer Detection Rate, Incidence, Prevalence and Interval Cancer-related Mammography Screening Times among Thai Women.
    Sripaiboonkij N; Thinkamrop B; Promthet S; Kannawat C; Tangcharoensathien V; Ansusing T; Rattanamongkolgul S
    Asian Pac J Cancer Prev; 2016; 17(8):4137-41. PubMed ID: 27644674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction of breast cancer screening in Chernihiv Oblast in the Ukraine: report of a PATH Breast Cancer Assistance Program experience.
    Zotov V; Shyyan R;
    Breast J; 2003; 9 Suppl 2():S75-80. PubMed ID: 12713500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer early detection methods for low and middle income countries, a review of the evidence.
    Corbex M; Burton R; Sancho-Garnier H
    Breast; 2012 Aug; 21(4):428-34. PubMed ID: 22289154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer screening in developing countries.
    da Costa Vieira RA; Biller G; Uemura G; Ruiz CA; Curado MP
    Clinics (Sao Paulo); 2017 Apr; 72(4):244-253. PubMed ID: 28492725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality-of-life effects of screening mammography in Norway.
    Zahl PH; Kalager M; Suhrke P; Nord E
    Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early diagnosis and detection of breast cancer.
    Milosevic M; Jankovic D; Milenkovic A; Stojanov D
    Technol Health Care; 2018; 26(4):729-759. PubMed ID: 30124455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
    Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rethinking breast cancer screening strategies in resource-limited settings.
    Galukande M; Kiguli-Malwadde E
    Afr Health Sci; 2010 Mar; 10(1):89-92. PubMed ID: 20811531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(15):1-71. PubMed ID: 27468326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Analysis of Breast Cancer Incidence Rates between Australia and Japan: Screening Target Implications.
    Mizukoshi MM; Hossian SZ; Poulos A
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2123-2129. PubMed ID: 32711441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.